CacheBy
Thermo Fisher Scientific Natalizumab Humanized Recombinant Human Monoclonal Antibody
원본

Thermo Fisher Scientific Natalizumab Humanized Recombinant Human Monoclonal Antibody

상품 한눈에 보기

Natalizumab은 인간화된 재조합 단일클론 항체로, α4β1 인테그린과 VCAM-1의 결합을 차단합니다. 다발성 경화증 및 크론병 연구에 활용됩니다. ELISA 등 다양한 응용 가능하며, 고순도 Protein A 정제 및 낮은 엔도톡신 수준을 제공합니다.

카탈로그번호
MA541714
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 04. 오전 03:26
Thermo Fisher Scientific MA541714 Natalizumab Humanized Recombinant Human Monoclonal Antibody 100 ug pk판매 단위 pk ·
재고 확인 필요
714,600원VAT 포함 786,060원

Thermo Fisher Scientific · Thermo Fisher Scientific Natalizumab Humanized Recombinant Human Monoclonal Antibody

Applications

  • ELISA (Assay-dependent)

Product Specifications

항목 내용
Species Reactivity Human
Host / Isotype Human / IgG4, kappa
Expression System CHO cells
Class Recombinant Monoclonal
Type Antibody
Immunogen Human ITGA4/CD49d
Conjugate Unconjugated
Form Liquid
Concentration 1.18 mg/mL
Purification Protein A
Storage Buffer PBS, pH 7.4
Contains No preservative
Storage Conditions -20°C, Avoid Freeze/Thaw Cycles
Shipping Conditions Ambient (domestic); Wet ice (international)
RRID AB_2910857

Product Specific Information

  • Endotoxin level < 0.01 EU/µg by LAL method
  • Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • Store at 2–8°C for one week.
  • Store at -20 to -80°C for twelve months from the date of receipt.

Target Information

Natalizumab is a recombinant, humanized monoclonal antibody that binds to alpha4beta1 integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1).
It is used for research related to relapsing-remitting multiple sclerosis and Crohn’s disease.
Natalizumab represents the first targeted therapy blocking lymphocyte entry into the CNS, preventing acute demyelinating relapses.

For Research Use Only.
Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.